Results 211 to 220 of about 175,837 (263)

Evaluating Gene Fusions as Prognostic Biomarkers and Therapeutic Targets in Immune Checkpoint Blockade-Treated Advanced Melanoma: A Retrospective Analysis. [PDF]

Cancer Res Commun
Nibeyro G, Baronetto VM, Nava A, Girotti MR, Prato L, Morón G, Fernández EA.   +6 more
europepmc   +1 more source

Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study

Head &Neck, EarlyView.
ABSTRACT Introduction Sinonasal cancers are rare and heterogeneous and pose a therapeutic challenge at an advanced stage due to the lack of data on appropriate systemic management. Methods This retrospective multicenter study analyzed 83 patients with recurrent or metastatic sinonasal carcinomas ineligible for curative treatment, treated in France ...
Marie Degrange, Mathilde Morisseau, Justin Michel, Thibaut Reverdy, Sylvain Morinière, Amaury Daste, Maxime Humbert, Caroline Viala, Pauline Corbaux, Tiffany Darbas, François‐Régis Ferrand, Valentin Favier, Camille Evrard, Diane Evrard, Delphine Farneti, Sarah Betrian‐Lagarde, Victor Sarradin   +16 more
wiley   +1 more source

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047. [PDF]

J Immunother Cancer
Regan MM, Ascierto PA, Lipson EJ, Palaia J, Moshyk A, Selvan A, Lao CD, Atkins MB, McDermott DF, Potluri R, Ranjan S, Bilthare S, Long GV, Stephen Hodi F, Tawbi H, Schadendorf D.   +15 more
europepmc   +1 more source

Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

Head &Neck, EarlyView.
ABSTRACT Background Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base
Michael J. C. Schachtel, Benedict J. Panizza, James J. Bowman, Catherine Barnett, Cristina Valero, Ian Ganly, Snehal G. Patel, Helena Levyn, Dauren Adilbay, Alana Eagan, Marc A. Cohen, Lillian A. Boe, Junting Zheng, Mithat Gonen, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Luiz P. Kowalski, Ronaldo N. Toledo, Claudio Cernea, Sergio Goncalves, Dan M. Fliss, John R. de Almeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Alvaro Rivero Calle, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard J. Harvey, C. Rene Leemans, Jan‐Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ken Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Rodney J. Schlosser, Fernando L. Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna, Jatin P. Shah   +52 more
wiley   +1 more source

Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data. [PDF]

Cancers (Basel)
Lens M, Schachter J.
europepmc   +1 more source

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study. [PDF]

J Natl Cancer Inst
Schuiveling M, Ter Maat LS, Van Duin IAJ, Verheijden RJ, Troenokarso MF, Moeskops P, Verhoeff JJC, Elias SG, van Amsterdam WAC, Burgers F, Van den Berkmortel FWPJ, Boers-Sonderen MJ, Boomsma MF, De Groot JW, Haanen JBAG, Hospers GAP, Piersma D, Vreugdenhil G, Westgeest HM, Kapiteijn E, Labots M, Veldhuis WB, Van Diest PJ, De Jong PA, Pluim JPW, Leiner T, Veta M, Suijkerbuijk KPM.   +27 more
europepmc   +1 more source

Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison. [PDF]

BMJ Oncol
Miller DM, Smithy JW, Palaia J, Patel D, Salvatore A, D'Adamo D, Mattera M, Zhou ZY, Garcia-Horton V, Tarhini AA.   +9 more
europepmc   +1 more source

Advanced Melanoma Management: A Case Report of Pembrolizumab Use in a Haemodialysis Patient. [PDF]

Cureus
Teixeira C, Costa R, Silva M, Ribeiro MJ, Sousa I.   +4 more
europepmc   +1 more source

Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma. [PDF]

Cancers (Basel)
Criado-Otero M, Navedo-de Las Heras M, Samaniego-González E.   +2 more
europepmc   +1 more source

Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge

Schuiveling M, Liu H, Eek D, Hanusová M, van Duin IA, ter Maat LS, van der Weerd JC, van den Berkmortel F, Blank CU, Breimer GE, Burgers FH, Boers-Sonderen M, van den Eertwegh AJ, de Groot JWB, Haanen JB, Hospers GA, Kapiteijn E, Piersma D, Simkens L, Westgeest HM, Schrader AM, van Diest PJ, Lv J, Zhu Y, Tenorio CGC, Chohan BS, Eastwood M, Raza SEA, Torbati N, Meshcheryakova A, Mechtcheriakova D, Mahbod A, Adams D, Galdran A, Pluim JP, Blokx WA, Suijkerbuijk KP, Veta M.   +37 more
europepmc   +1 more source